FDA advisors recommend AstraZeneca antibody to protect babies from RSV
Narisara Nami | Moment | Getty ImagesA panel of independent advisors to the Food and Drug Administration unanimously recommended Thursday that the antibody nirsevimab be approved for use to protect infants from respiratory syncytial virus,…